Bill > H1925

This bill establishes provisions for the return of expired pharmaceuticals, requiring manufacturers of controlled substances to provide a mechanism for pharmacies to return outdated drugs, excluding certain types like biologicals or intravenously injected drugs, within six months of their expiration date for full credit or refund. Wholesale drug businesses licensed under section 36A of chapter 112 are tasked with implementing these manufacturer-established return policies. Manufacturers must also inform the Department of Public Health about their return policies, and failure to comply could result in their products being deemed ineligible for use in state-funded programs, with the Commissioner of Public Health authorized to create regulations to enforce these new rules.